-transparent.png){kind=logo}
Diethyldithiocarbamate (DDTC), N-methyl-N-dithiocarboxyglucamine (MDCG), and 4-carboxamidopiperidine-N-dithiocarboxylate (CAP-N-DTC) were compared at equimolar doses administered by the ip and po routes for effectiveness in mobilizing metallothionein (MT)-bound cadmium (Cd) using 109Cd in mice. DDTC was highly effective by both routes in lowering hepatic, renal, and splenic Cd levels, but enhanced redistribution of Cd to testes and brain. While MDCG and CAP-N-DTC were much less active by the oral route, each effected a significant reduction of renal Cd levels, and MDCG reduced the testicular Cd burden. Neither analog lowered hepatic Cd levels impressively when given po.
Related Publications
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
March 1989,
Pharmacology & toxicology,
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
July 1990,
Research communications in chemical pathology and pharmacology,
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
January 1991,
Toxicology,
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
November 1990,
Chemical & pharmaceutical bulletin,
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
January 1999,
Acta physiologica Hungarica,
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
March 1980,
Acta pharmacologica et toxicologica,
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
January 1986,
Journal of toxicology and environmental health,
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
June 1984,
Toxicology and applied pharmacology,
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
January 1978,
Journal of toxicology and environmental health,
G R Gale, and
L M Atkins, and
A B Smith, and
M M Jones
March 1988,
Toxicology,
